• Patient Age & Gender: 80 years / F
• Type of Cancer: Liver Cancer
• No. of Therapy Given: 9 Cycle
• Pt. testimonial after 16 Months
  Since the start of immunotherapy patient has completed 3 years with an absolutely normal healthy life

• Age: 43 years
• Cancer Type: Esophageal cancer
• Diagnosis Date: January 2024
• Stage at Diagnosis: Stage 4
• Initial Treatment Suggested: Surgery followed by chemotherapy (standard procedure).
• Start of chemotherapy: Around 20 days after surgery.
• Immunotherapy Start: Concurrently with chemotherapy cycles, during the gap between each chemotherapy cycle.
• Number of chemotherapy cycles: 6 completed.
• Number of immunotherapy cycles: 6 completed, administered every 21 days.

Recovery and Current Health:

• Returned to work and daily routine within 10-14 days post-surgery.
• Driving, climbing stairs, and leading a normal life.
• Feels healthy and has almost forgotten about the cancer.

• Patient Age & Gender: 60 yrs – Female
• Consulted in: March 2023
• Type of Cancer: Ovary Cancer Recurrence
• Before Coming to Dr. Vikesh Shah, the Patient Had Undergone: Surgery & Chemotherapy
• Patient’s issue: She had cancer recurrence with multiple abdominal, liver, and lymph node metastases.
• Patient’s concern: Loss Of Weight, Decreased Appetite, Extreme Fatigue, Pain & Patient Was Depressed
• No. of dendritic cell immunotherapy cycle given: 6 cycles
• Post-therapy condition: The patient gained more than 5 kg of weight, her appetite increased, and fatigue & pain disappeared.
• It has been more than 18 months since the patient was started on dendritic cell immunotherapy treatment, and the patient is living a healthy & happy life with no restrictions in physical quality of life.
• Patient & Patients Relatives Are Thankful To Dr. Vikesh Shah & His Team.
• Patient testimonial after : 3 months

• Patient Age: 20 yrs / Male
• Type of Cancer: Bone Cancer – Osteosarcoma with multiple Metastases
• No. of Therapy: 6 cycle
• Report After: 6 cycle
• Patient History: Both Lungs, Mediastinum, Liver, L for Vertebral Metastasis
• After 6 cycles: Significant reduction of cancer at most of the metastatic cancer sites.
• Almost all lesions have become non-FDG avid (except the mediastinal mass showing very minimal FDG uptake).
• There is an increase in the size of the lesions (pseudoprogression) in some areas, which is due to the classical dendritic immunotherapy response.

• Patient Age & Gender: 82 yrs – Male
• Type of Cancer: Multiple Myeloma
• Consultation Period: July 2023
• Condition when came for consultation: Complaints of recurrent fever, extreme tiredness, fatigue, asthenia (lack of energy), decreased appetite, body pains, etc.
• Patient’s bone marrow report in July 2023.
• PLASMA CELL COUNT: 66% (INCREASED IN BONE MARROW).
• HIS BETA 2 MICRO GLOBULIN WAS 4711.0 NG/ML (high).
• After 4 cycles of dendritic immunotherapy, when follow-up tests were done, BETA-2 MICROGLOBUTIN LEVELS DECREASED 3690 NG/ML.
• Plasma Cell count in bone marrow: Decreased to 30%
• Reports started showing a good response to treatment.
• Clinical symptoms also started improving.
• Another 2 cycles were given, & when beta-2 microglobulin was done in January 2024, ITS LEVELS DECREASED TO 3020 NG/1.
• All his clinical symptoms improved.
• Currently, the patient is doing good and has planned for booster cycles of dendritic cancer immunotherapy to maintain the treatment response.
• The patient & patient’s relatives are extremely thankful to Dr. Vikesh Shah & his team.